Declining hepatitis a mortality in the United States during the era of hepatitis A vaccination

Journal of Infectious Diseases

Volumn 197, Issue 9, 2008, Pages 1282-1288

  Vogt, Tara M ^a   Wise, Matthew E ^b   Bell, Beth P ^a,c   Finelli, Lyn ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHILD; FEMALE; HEPATITIS A; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREND STUDY; UNITED STATES; VACCINATION;

DEATH CERTIFICATES; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; UNITED STATES; VACCINATION;

EID: 43049095145     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/586899     Document Type: Article

References (38)

1. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-23.
2. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996; 45:1-30.
3. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48:1-37.
4. Keeffe EB. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med 2005; 118(Suppl 10A):21S-7S.
5. Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. J Clin Gastroenterol 2001; 33:20-6.
6. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005; 294:194-201.
7. Centers for Disease Control and Prevention. Hepatitis surveillance report. Report no. 61. Atlanta: US Department of Health and Human Services; 2006.
8. Wasley A, Miller JT, Finelli L. Surveillance for acute viral hepatitis - United States, 2005. MMWR Surveill Summ 2007; 56:1-24.
9. Samandari T, Bell BP, Armstrong GL. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 2004; 22:4342-50.
10. Wise ME, Sorvillo F. Hepatitis A-related mortality in California, 1989-2000: analysis of multiple cause-coded death data. Am J Public Health 2005; 95:900-5.
11. National Center for Health Statistics. National vital statistics system. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2006.
12. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva: World Health Organization, 1980.
13. World Health Organization. International Classification of Diseases, Tenth Revision. Geneva: World Health Organization, 1999.
14. National Center for Health Statistics. Public use data tape documentation: multiple cause of death for ICD-9 1990 data. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, 1993.
15. National Center for Health Statistics. Public use data tape documentation: multiple cause of death for ICD-9 1997 data. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, 1999.
16. National Center for Health Statistics. US vital statistics systems: major developments, 1950-1995. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 1997.
17. Centers for Disease Control and Prevention. Guidelines for viral hepatitis surveillance and case management. Atlanta: US Department of Health and Human Services, 2005.
18. National Center for Health Statistics. Estimates of the July 1, 2000-July 1, 2004, United States resident population from the Vintage 2004 postcensal series by year, county, age, sex, race, and Hispanic origin, prepared under a collaborative arrangement with the U.S. Census Bureau. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2006.
19. Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 1998; 47:1-16, 20.
20. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes 2001; 20:1-10.
21. Hakulinen T. A Mantel-Haenszel statistic for testing the association between a polychotomous exposure and a rare outcome. Am J Epidemiol 1981; 113:192-7.
22. Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol 2002; 156:761-73.
23. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90:1562-9.
24. Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31:777-82.
25. Arguedas MR, McGuire BM, Fallon MB. Implementation of vaccination in patients with cirrhosis. Dig Dis Sci 2002; 47:384-7.
26. Shim M, Khaykis I, Park J, Bini EJ. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 2005; 42:688-95.
27. Carey J, Perlman DC, Friedmann P, et al. Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat 2005; 29:47-53.
28. Diamond C, Thiede H, Perdue T, et al. Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination. Sex Transm Dis 2003; 30:425-32.
29. Averhoff F, Shapiro CN, Bell BP, et al. Control of hepatitis A through routine vaccination of children. JAMA 2001; 286:2968-73.
30. Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002; 109:839-45.
31. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294:202-10.
32. Bialek SR, Terrault NA. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006; 10:697-715.
33. Vong S, Fiore AE, Haight DO, et al. Vaccination in the county jail as a strategy to reach high risk adults during a community-based hepatitis A outbreak among methamphetamine drug users. Vaccine 2005; 23:1021-8.
34. Rein D, Hicks KA, Wirth KE, et al. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics 2007; 119:e12-21.
35. Schiodt FV, Davern TJ, Shakil AO, McGuire B, Samuel G, Lee WM. Viral hepatitis-related acute liver failure. Am J Gastroenterol 2003; 98:448-53.
36. Taylor RM, Davern T, Munoz S, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 2006; 44:1589-97.
37. Rosenberg HM, Maurer JD, Sorlie PD, et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital Health Stat 2 1999; 128:1-13.
38. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001; 49:1-32.